Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

GKOS

Glaukos Corporation

Feb 10 • 12:45PM ET

114.39

+1.12 0.99 %

Healthcare • Medical Devices • USA • NYSE

Peers: ALGN ZBH BSX EW ISRG MDT SYK COO BAX HOLX

| Held by: IJR VTI IWM VB VBK VXF SPSM IWO IJT SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.55	Insider Own	4.25%	Shs Outstand	57.39M	Perf Week	-3.17%
Market Cap	6.57B	Forward P/E	-	EPS next Y	-0.32	Insider Trans	-12.08%	Shs Float	55.00M	Perf Month	1.30%
Enterprise Value	6.40B	PEG	-	EPS next Q	-0.20	Inst Own	100.55%	Short Float	4.05%	Perf Quarter	36.41%
Income	-87.61M	P/S	13.98	EPS this Y	56.14%	Inst Trans	-6.44%	Short Ratio	2.54	Perf Half Y	31.45%
Sales	469.82M	P/B	8.53	EPS next Y	60.85%	ROA	-9.10%	Short Interest	2.23M	Perf YTD	1.31%
Book/sh	13.41	P/C	24.00	EPS next 5Y	-	ROE	-12.19%	52W High	161.78 -29.29%	Perf Year	-25.27%
Cash/sh	4.77	P/FCF	-	EPS past 3/5Y	-37.46% -	ROIC	-10.03%	52W Low	73.16 56.36%	Perf 3Y	122.03%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.26% 10.10%	Gross Margin	76.87%	Volatility	3.95% 5.11%	Perf 5Y	23.48%
Dividend TTM	-	EV/Sales	13.62	EPS Y/Y TTM	47.64%	Oper. Margin	-18.82%	ATR (14)	5.03	Perf 10Y	578.87%
Dividend Ex-Date	-	Quick Ratio	4.47	Sales Y/Y TTM	30.38%	Profit Margin	-18.65%	RSI (14)	48.04	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	5.20	EPS Q/Q	27.30%	SMA20	-2.74%	Beta	0.71	Target Price	132.71
Payout	-	Debt/Eq	0.14	Sales Q/Q	38.14%	SMA50	0.32%	Rel Volume	0.25	Prev Close	113.27
Employees	995	LT Debt/Eq	0.14	Earnings	Feb 17 AMC	SMA200	17.89%	Avg Volume	874.91K	Price	114.39
IPO	Jun 25, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.60% 9.06%	Trades		Volume	112,744	Change	0.99%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-27-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$120
Oct-01-25	Initiated	Goldman	Buy	$103
May-01-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$86
Feb-19-25	Upgrade	Mizuho	Neutral → Outperform	$140 → $200
Dec-11-24	Upgrade	Citigroup	Neutral → Buy	$132 → $162
Dec-06-24	Initiated	UBS	Buy	$182
Dec-02-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$120
Jul-10-24	Downgrade	Citigroup	Buy → Neutral	$132
May-06-24	Upgrade	Jefferies	Hold → Buy	$84 → $125
Dec-21-23	Upgrade	JP Morgan	Neutral → Overweight	$66 → $91
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$65
Nov-28-23	Initiated	Truist	Buy	$88
Nov-08-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$75 → $83
Jun-07-23	Upgrade	Piper Sandler	Neutral → Overweight	$55 → $80
Dec-22-22	Initiated	Mizuho	Neutral	$48
Dec-19-22	Upgrade	JP Morgan	Underweight → Neutral	$48 → $42
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$57
Oct-14-22	Resumed	Stephens	Overweight	$69
Oct-04-22	Initiated	Needham	Buy	$66
Jul-12-22	Upgrade	Stifel	Hold → Buy	$40 → $60

Show Previous Ratings

Today 10:00AM	Glaukos (GKOS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jan-29-26 09:55AM	Wells sees potential upside after Glaukos iDose repeat dosing label approved (TipRanks)
08:32AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Jan-28-26 07:00AM	Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose TR (Business Wire)
Jan-22-26 04:30AM	What Makes Glaukos (GKOS) a Good Investment? (Insider Monkey)
07:00AM	Loading…
Jan-20-26 07:00AM	Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17 (Business Wire)
Jan-14-26 04:39PM	Stock Indexes Settle Lower on Tech Weakness (Barchart) -5.26% +9.62%
04:19PM	Intuitive Surgical Crushed Fourth-Quarter Forecasts. So Why Did Shares Dive? (Investor's Business Daily)
Jan-13-26 04:05PM	Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance (Business Wire)
Jan-03-26 07:20AM	Klaviyo, Wingstop among Stephens Best Ideas for 2026 (TipRanks)
07:10AM	Glaukos price target raised to $145 from $115 at Stephens (TipRanks)
Dec-29-25 08:52AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Dec-16-25 07:00AM	Glaukos Announces Participation in J.P. Morgan Healthcare Conference (Business Wire)
Dec-05-25 11:30AM	Inogen (INGN) Down 0.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Dec-03-25 11:30AM	Idexx (IDXX) Up 1.5% Since Last Earnings Report: Can It Continue? (Zacks)
12:44PM	Loading…
Nov-28-25 12:44PM	Here's Why You Should Retain Glaukos Stock in Your Portfolio (Zacks)
11:30AM	Glaukos (GKOS) Up 20% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-05-25 06:08AM	Beaten Down by 35%-Plus: Analysts Say These 2 Oversold Stocks Are Poised to Turn the Corner (TipRanks)
Nov-03-25 07:00AM	Glaukos Announces Participation in Upcoming Investor Conferences (Business Wire)
Oct-31-25 06:03PM	Here's What Key Metrics Tell Us About Glaukos (GKOS) Q3 Earnings (Zacks)
Oct-30-25 06:54PM	Why Glaukos Stock Zoomed Almost 14% Higher on Thursday (Motley Fool) +13.89%
04:06PM	Glaukos Corp (GKOS) Q3 2025 Earnings Call Highlights: Record Sales and Strategic Advancements (GuruFocus.com)
12:21PM	GKOS Stock Surges Following Q3 Earnings & Revenue Beat, Guidance Raised (Zacks)
Oct-29-25 05:55PM	Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:51PM	Glaukos: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Glaukos Announces Third Quarter 2025 Financial Results (Business Wire)
Oct-28-25 09:33AM	What To Expect From Glaukos Corp (GKOS) Q3 2025 Earnings (GuruFocus.com)
08:15AM	IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates (Zacks)
Oct-27-25 09:44AM	Microsoft upgraded, Harley-Davidson downgraded: Wall Street's top analyst calls (The Fly)
Oct-23-25 10:00AM	DexCom (DXCM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
10:00AM	Loading…
Oct-22-25 10:00AM	Will Glaukos (GKOS) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-20-25 07:00AM	Glaukos Announces FDA Approval of Epioxa (Business Wire) -8.83%
06:31AM	Glaukos Corporation (GKOS) Eye Treatment Epioxa Poised for Strong Market Uptake, Says Stifel (Insider Monkey)
Oct-14-25 07:00AM	Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting (Business Wire)
Oct-08-25 07:00AM	Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29 (Business Wire)
Oct-01-25 11:01AM	Goldman Sachs initiates ophthalmology coverage: Buy Glaukos, sell Cooper (Investing.com)
Sep-25-25 04:05PM	Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama (Business Wire)
Sep-18-25 10:40AM	Glaukos Corporation (GKOS) Advances Next-Gen Glaucoma and Corneal Therapies, Eyes FDA Approval for Epioxa (Insider Monkey)
Sep-02-25 10:10AM	Glaukos Builds Dual Growth Engines Amid Market Headwinds (Zacks)
Aug-13-25 07:00AM	Glaukos Announces Participation in Wells Fargo Healthcare Conference (Business Wire)
Jul-31-25 01:27PM	GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised (Zacks) -8.46%
Jul-30-25 05:45PM	Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:43PM	Glaukos: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Glaukos Announces Second Quarter 2025 Financial Results (Business Wire)
Jul-29-25 09:30AM	Glaukos Corp (GKOS) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jul-09-25 08:18AM	Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks (Zacks)
07:00AM	Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30 (Business Wire)
Jul-08-25 08:00AM	FELIQS Appoints Gregory Kunst and Joe Zenkus to Board of Directors (Business Wire)
Jun-27-25 10:37AM	Glaukos gains EU certification for iStent infinite and other MIGS devices (Medical Device Network)
Jun-25-25 04:05PM	Glaukos Announces EU MDR Certification for iStent infinite and Other Leading MIGS Therapies (Business Wire)
08:55AM	NYSE Content Advisory: Pre-Market update + S&P 500 trades within 1% of record (PR Newswire)
07:00AM	Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell (Business Wire)
Jun-16-25 12:00PM	What Makes Glaukos (GKOS) a New Buy Stock (Zacks)
Jun-11-25 09:55AM	Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect? (Zacks)
May-21-25 07:17AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio (Zacks)
May-13-25 07:00AM	Glaukos Announces Participation in Upcoming Investor Conferences (Business Wire)
May-12-25 08:13AM	Glaukos Corporation (GKOS) Fell as its iDose Results Fell Short of Expectations (Insider Monkey) +5.20%
May-07-25 04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
May-01-25 12:00PM	Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -11.36%
11:32AM	GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline (Zacks)
11:04AM	Q1 2025 Glaukos Corp Earnings Call (Thomson Reuters StreetEvents)
03:17AM	Glaukos Corp (GKOS) Q1 2025 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... (GuruFocus.com)
Apr-30-25 10:05PM	Glaukos Corporation (GKOS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:25PM	Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:22PM	Glaukos: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Glaukos Announces First Quarter 2025 Financial Results (Business Wire)
Apr-29-25 01:10PM	ECL Stock Up in Pre-Market Following Q1 Earnings Meet Estimates (Zacks)
11:30AM	Baron Health Care Fund Q1 2025 Top Contributors And Detractors (Seeking Alpha)
Apr-28-25 01:18PM	RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up (Zacks)
11:24AM	Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y (Zacks)
Apr-27-25 02:22PM	Baron Health Care Fund Q1 2025 Shareholder Letter (Seeking Alpha)
Apr-25-25 12:50PM	Here's Why You Should Hold the GEHC Stock in Your Portfolio for Now (Zacks)
12:48PM	Integer Holdings Q1 Earnings & Revenues Beat Estimates, Margins Expand (Zacks)
Apr-24-25 01:02PM	Here's Why You Should Add Veeva Stock to Your Portfolio Now (Zacks)
11:36AM	WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit (Zacks)
10:01AM	Earnings Preview: Mettler-Toledo (MTD) Q1 Earnings Expected to Decline (Zacks)
Apr-23-25 12:39PM	ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts (Zacks)
10:01AM	Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
07:00AM	Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting (Business Wire)
Apr-16-25 07:00AM	Glaukos Announces the Release of its 2024 Sustainability Report (Business Wire) -6.05%
Apr-10-25 09:04AM	Strength Seen in Veracyte (VCYT): Can Its 13.0% Jump Turn into More Strength? (Zacks)
Apr-09-25 07:00AM	Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30 (Business Wire) +13.71%
Apr-08-25 09:41AM	What Makes Glaukos Corporation (GKOS) a Compelling Stock? (Insider Monkey)
Apr-07-25 08:00AM	ClearBridge Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-06-25 08:48AM	Glaukos: Macro Environment And Limited Market Access Could Stunt Growth Plans (Seeking Alpha)
Apr-02-25 12:01AM	Lord Abbett Developing Growth Fund Q4 2024 Commentary (Seeking Alpha)
Apr-01-25 10:49AM	The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals (Zacks)
Mar-31-25 09:10AM	3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space (Zacks)
Mar-28-25 03:59PM	Baird Q4 2024 Small/Mid Cap Growth Equity Commentary (Seeking Alpha)
Mar-27-25 11:15AM	Columbia Select Mid Cap Growth Fund Q4 2024 Commentary (SeekingAlpha)
Mar-26-25 11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
Mar-11-25 07:00AM	RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire: A Next-Generation Visual Field Solution (Business Wire)
Mar-04-25 11:52PM	Is Glaukos Corporation (GKOS) the Best Medical Technology Stock to Buy According to Analysts? (Insider Monkey)
Feb-24-25 07:00AM	Glaukos Announces FDA Acceptance of NDA Submission for Epioxa (Business Wire)
Feb-21-25 07:47PM	Wingstop Stocks Dip Is an Opportunity, Analyst Says. Plus, Devon Energy, Cadence Design, and More. (Barrons.com) -20.01%
02:15AM	Glaukos Corp (GKOS) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... (GuruFocus.com)
Feb-20-25 05:40PM	Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:34PM	Glaukos: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
12:00PM	Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz (TipRanks)

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stapley Marc	Director	Jan 22 '26	Option Exercise	24.69	15,000	370,350	52,449	Jan 26 09:21 PM
Stapley Marc	Director	Jan 22 '26	Sale	127.71	15,000	1,915,576	37,449	Jan 26 09:21 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 22 '26	Option Exercise	55.18	10,498	579,280	102,864	Jan 26 09:05 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 22 '26	Sale	127.68	10,498	1,340,380	92,366	Jan 26 09:05 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 21 '26	Option Exercise	55.18	4,502	248,420	96,868	Jan 23 08:42 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 21 '26	Sale	124.65	4,502	561,174	92,366	Jan 23 08:42 PM
Gilliam Joseph E	Officer	Jan 22 '26	Proposed Sale	127.68	10,498	1,340,378		Jan 22 04:27 PM
Stapley Marc	Director	Jan 22 '26	Proposed Sale	127.70	15,000	1,915,560		Jan 22 04:21 PM
Gilliam Joseph E	Officer	Jan 21 '26	Proposed Sale	124.65	4,502	561,168		Jan 21 04:40 PM
Burns Thomas William	CHAIRMAN & CEO	Jan 16 '26	Option Exercise	16.49	186,945	3,082,723	340,720	Jan 20 06:37 PM
Burns Thomas William	CHAIRMAN & CEO	Jan 08 '26	Option Exercise	16.49	88,055	1,452,027	241,830	Jan 20 06:37 PM
Burns Thomas William	CHAIRMAN & CEO	Jan 16 '26	Sale	115.00	186,945	21,498,675	153,775	Jan 20 06:37 PM
Burns Thomas William	CHAIRMAN & CEO	Jan 08 '26	Sale	115.00	88,055	10,126,325	153,775	Jan 20 06:37 PM
Burns Thomas William	Officer	Jan 16 '26	Proposed Sale	115.00	186,945	21,498,675		Jan 16 10:29 AM
Burns Thomas William	Officer	Jan 08 '26	Proposed Sale	115.00	88,055	10,126,325		Jan 08 04:09 PM
Kliman Gilbert H	Director	Dec 09 '25	Option Exercise	24.69	5,000	123,450	39,905	Dec 11 04:20 PM
Kliman Gilbert H	Director	Dec 09 '25	Sale	107.27	5,000	536,350	34,905	Dec 11 04:20 PM
Kliman Gilbert H	Director	Dec 09 '25	Proposed Sale	107.27	5,000	536,368		Dec 09 03:43 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Nov 25 '25	Sale	105.00	315	33,075	50,488	Nov 26 05:00 PM
Thurman Alex R.	Officer	Nov 25 '25	Proposed Sale	105.00	315	33,075		Nov 25 02:19 PM
Gilliam Joseph E	PRESIDENT & COO	Nov 18 '25	Sale	90.00	19,340	1,740,600	92,366	Nov 20 07:56 PM
Gilliam Joseph E	Officer	Nov 18 '25	Proposed Sale	90.00	19,340	1,740,600		Nov 18 12:41 PM
Navratil Tomas	CHIEF DEVELOPMENT OFFICER	Sep 22 '25	Sale	84.22	517	43,541	76,390	Sep 24 06:53 PM
Navratil Tomas	Officer	Sep 22 '25	Proposed Sale	84.22	517	43,541		Sep 22 04:36 PM
Navratil Tomas	CHIEF DEVELOPMENT OFFICER	Sep 11 '25	Sale	88.22	5,142	453,620	75,469	Sep 12 08:42 PM
Navratil Tomas	Officer	Sep 11 '25	Proposed Sale	88.22	5,142	453,608		Sep 11 04:38 PM
Hoffmeister David F	Director	Jun 11 '25	Option Exercise	32.00	25,000	800,000	31,918	Jun 13 07:43 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Mar 25 '25	Sale	106.84	1,520	162,399	53,431	Mar 27 07:14 PM
Thurman Alex R.	Officer	Mar 25 '25	Proposed Sale	106.84	1,520	162,402		Mar 25 04:23 PM
Foley Mark J	Director	Feb 26 '25	Option Exercise	29.26	40,000	1,170,350	74,936	Feb 28 05:57 PM
Foley Mark J	Director	Feb 26 '25	Sale	120.72	20,687	2,497,335	54,249	Feb 28 05:57 PM
Foley Mark J	Director	Feb 26 '25	Proposed Sale	120.72	20,687	2,497,263		Feb 26 03:57 PM
Navratil Tomas	CHIEF DEVELOPMENT OFFICER	Feb 14 '25	Sale	147.14	3,416	502,630	72,437	Feb 19 06:00 PM
Navratil Tomas	Officer	Feb 14 '25	Proposed Sale	147.14	3,416	502,630		Feb 14 10:13 AM

Open in Screener

STAA

Staar Surgical Co

Feb 10 • 12:45PM ET

17.48

+0.07 0.40 %

Healthcare • Medical Instruments & Supplies • USA • NASD

STAA Staar Surgical Co daily Stock Chart

Peers: JNJ ALGN ISRG MDT ABT NVS BSX EW EYE SYK

| Held by: IJR VTI IWM VB VXF VBK SPSM IWO VTWO SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.96	Insider Own	0.85%	Shs Outstand	49.35M	Perf Week	-3.69%
Market Cap	869.49M	Forward P/E	41.33	EPS next Y	0.42	Insider Trans	457.45%	Shs Float	49.32M	Perf Month	-20.98%
Enterprise Value	715.95M	PEG	0.92	EPS next Q	0.18	Inst Own	106.35%	Short Float	8.18%	Perf Quarter	-34.16%
Income	-96.37M	P/S	3.77	EPS this Y	-89.53%	Inst Trans	-10.32%	Short Ratio	2.93	Perf Half Y	-35.97%
Sales	230.59M	P/B	2.44	EPS next Y	1779.75%	ROA	-19.39%	Short Interest	4.03M	Perf YTD	-24.30%
Book/sh	7.17	P/C	4.51	EPS next 5Y	44.75%	ROE	-24.65%	52W High	30.81 -43.27%	Perf Year	-20.36%
Cash/sh	3.87	P/FCF	-	EPS past 3/5Y	- -	ROIC	-24.86%	52W Low	13.50 29.48%	Perf 3Y	-77.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.85% 15.89%	Gross Margin	72.18%	Volatility	4.14% 4.61%	Perf 5Y	-84.10%
Dividend TTM	-	EV/Sales	3.10	EPS Y/Y TTM	-540.37%	Oper. Margin	-28.42%	ATR (14)	0.88	Perf 10Y	174.84%
Dividend Ex-Date	-	Quick Ratio	4.35	Sales Y/Y TTM	-32.42%	Profit Margin	-41.79%	RSI (14)	27.42	Recom	3.18
Dividend Gr. 3/5Y	- -	Current Ratio	5.21	EPS Q/Q	-12.41%	SMA20	-8.95%	Beta	1.07	Target Price	23.53
Payout	-	Debt/Eq	0.11	Sales Q/Q	6.93%	SMA50	-21.21%	Rel Volume	0.60	Prev Close	17.41
Employees	1211	LT Debt/Eq	0.10	Earnings	Nov 05 AMC	SMA200	-22.78%	Avg Volume	1.38M	Price	17.48
IPO	Jul 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.16% 0.03%	Trades		Volume	431,131	Change	0.40%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-03-26	Initiated	Wedbush	Neutral	$26
Jan-16-26	Resumed	Morgan Stanley	Underweight	$13
Apr-21-25	Initiated	Wells Fargo	Equal Weight	$17
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-12-25	Downgrade	Mizuho	Outperform → Neutral	$45 → $17
Feb-12-25	Downgrade	Jefferies	Buy → Hold
Feb-12-25	Downgrade	BTIG Research	Buy → Neutral
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$50 → $37
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy	$46
Mar-11-24	Upgrade	Stifel	Hold → Buy	$30 → $50
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$35
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold	$77 → $48
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral	$65
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy	$80 → $67
Dec-08-22	Initiated	Stifel	Hold	$60
Nov-07-22	Upgrade	Sidoti	Neutral → Buy

Show Previous Ratings

Feb-05-26 10:00AM	West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy? (Zacks)
07:55AM	Cardinal Health (CAH) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Feb-04-26 01:27PM	STAAR Surgical Company (STAA): A Bull Case Theory (Insider Monkey)
Feb-03-26 10:00AM	Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks)
09:34AM	Adobe downgraded, Palantir upgraded: Wall Street's top analyst calls (The Fly)
05:23AM	Loading…
05:23AM	STAAR names interim co-CEOs amid search for permanent leader (MedTech Dive)
Feb-02-26 12:55PM	Why STAAR Surgical (STAA) Stock Is Trading Lower Today (StockStory)
07:00AM	STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs (Business Wire)
Jan-30-26 01:00PM	Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems (Benzinga)
Jan-25-26 08:18PM	Analysts Question STAAR Surgical Company (STAA)'s Post-Merger Standalone Valuation (Insider Monkey)
Jan-23-26 04:35PM	Staar Surgical, Dynatrace, and More Stocks See Action From Activist Investors (Barrons.com)
Jan-16-26 08:39PM	Staar Surgical, Alumis, and More Stocks See Action From Activist Investors (Barrons.com)
09:32AM	Seagate upgraded, Tractor Supply downgraded: Wall Street's top analyst calls (The Fly)
08:02AM	Here Are Fridays Top Wall Street Analyst Research Calls: ConocoPhillips, Devon Energy, Garmin, Honeywell, HP, PepsiCo, Rocket Labs, Seagate, and More (24/7 Wall St.)
05:00AM	STAAR CEO exits after company rejects Alcon buyout (MedTech Dive)
11:04PM	Loading…
Jan-15-26 11:04PM	STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
01:06PM	STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence (Benzinga)
08:30AM	STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement (Business Wire)
Jan-13-26 08:45AM	Mitsui Sumitomo Continues to Build WR Berkley Stake (24/7 Wall St.)
Jan-07-26 07:38AM	STAAR Surgical terminates Alcon merger agreement (Medical Device Network)
Jan-06-26 08:00PM	Alcon Terminates Agreement to Acquire STAAR Surgical (Business Wire) -6.91%
12:32PM	Health Care Roundup: Market Talk (The Wall Street Journal)
12:14PM	Exclusive: STAAR Surgical deal fails as shareholder support remains at around 30% (Investing.com)
09:52AM	Broadwood Partners Comments on STAAR Surgical Shareholders Rejection of the Companys Proposed Sale to Alcon (Business Wire)
08:47AM	STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders (Business Wire)
06:13AM	STAAR shareholders reject Alcons revised buyout offer (MedTech Dive)
Dec-19-25 03:51PM	Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for (Investing.com)
12:59PM	Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon (Business Wire)
11:45AM	Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders (Business Wire)
Dec-17-25 06:47PM	Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day (Investing.com) -7.22%
04:53PM	Loading…
04:53PM	Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. (PR Newswire)
01:17PM	Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails (Business Wire)
10:55AM	STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value (Business Wire)
Dec-16-25 03:58PM	ISS recommends STAAR Surgical deal, but warns shareholders have reason to object (Investing.com) +5.26%
01:32PM	Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory (Business Wire)
09:12AM	Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction (Business Wire)
07:00AM	Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon (Business Wire)
Dec-15-25 06:35PM	Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote "FOR" Alcon Merger (Business Wire)
Dec-12-25 05:29PM	Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance against (Investing.com)
08:40AM	Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation "AGAINST" STAAR Surgical Sale to Alcon (Business Wire)
Dec-11-25 08:06PM	STAAR Surgical accuses activist Broadwood of misinformation campaign (Investing.com)
11:41AM	Why STAAR Surgical (STAA) Stock Is Up Today (StockStory)
09:47AM	STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process (Business Wire)
07:00AM	Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon (Business Wire)
Dec-10-25 01:34PM	STAAR Surgical falls as Yunqi Capital reiterates opposition to merger with Alcon (Investing.com) -5.50%
07:05AM	Yunqi Capital Comments on STAAR Surgical's Go-Shop Process and Alcon's Revised Offer (Business Wire)
Dec-09-25 02:25PM	Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against (Investing.com) +7.84%
02:16PM	STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know (StockStory)
12:39PM	Broadwood Partners Responds to Alcon's Increase to Proposed Acquisition Price of STAAR Surgical (Business Wire)
12:00PM	What Makes Staar Surgical (STAA) a New Buy Stock (Zacks)
08:30AM	Alcon Announces Amended Merger Agreement with STAAR Surgical (Business Wire)
Dec-08-25 04:11PM	Why STAAR Surgical (STAA) Shares Are Plunging Today (StockStory) -7.25%
01:28PM	Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process (Business Wire)
08:16AM	Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon (Business Wire)
08:00AM	STAAR Surgical Announces Expiration of Go-Shop Period (Business Wire)
Dec-04-25 10:35PM	STAAR Surgical (NASDAQ:STAA) Q3 Earnings: Leading The Medical Devices & Supplies - Specialty Pack (StockStory)
Dec-03-25 12:02PM	Broadwood reiterates push for STAAR Surgical board shake-up as Alcon vote nears (Investing.com)
Dec-02-25 04:14PM	Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors (Business Wire)
Nov-26-25 03:34PM	Staar Surgical, Gold Royalty See Activist Action (Barrons.com)
Nov-18-25 04:15PM	STAAR Surgical reveals board dissent over amended Alcon deal ahead of vote (Investing.com)
Nov-12-25 02:35PM	Exclusive: Broadwood says Alcons earnings reveal STAAR bid came from weakness (Investing.com) -5.66%
Nov-10-25 06:38PM	Broadwood continues pressure on STAAR board, urges new directors amid go-shop move (Investing.com)
01:00PM	STAARs largest shareholder requests new directors in ongoing Alcon merger dispute (Medical Device Network)
08:00AM	Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process (Business Wire)
Nov-07-25 04:22PM	STAAR Surgical opens go-shop window amid shareholder revolt over Alcon deal (Investing.com)
10:10AM	STAAR Surgical Announces Amendments to Alcon Merger Agreement (Business Wire)
Nov-06-25 06:21AM	Yunqi Capital Applauds STAAR Surgicals Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated (Business Wire) +5.47%
Nov-05-25 04:27PM	Staar Surgical: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Third Quarter 2025 Results (Business Wire)
Nov-04-25 11:32PM	3 Stocks Under $50 We Keep Off Our Radar (StockStory)
03:13PM	Alcon, Broadwood trade blows in fight for STAAR Surgicals future (Investing.com)
11:52AM	Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects (Business Wire)
01:00AM	Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders (Business Wire)
Oct-31-25 12:00PM	Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon (Business Wire)
11:14AM	Alcon rejects raised bid for STAAR Surgical as shareholders revolt (Investing.com)
Oct-27-25 04:43PM	Short Sellers Are Targeting Small-Caps. Megacaps Are Getting a Pass. (Barrons.com) +5.75%
08:00AM	STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon (Business Wire)
Oct-24-25 06:03PM	Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon (Business Wire)
01:59PM	Exclusive: Roughly 72% of STAAR Surgical shares oppose Alcon deal, vote delayed (Investing.com)
08:00AM	Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction (Business Wire)
Oct-23-25 12:09PM	Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders (Business Wire) +8.27%
Oct-22-25 02:35PM	Broadwood moves to oust STAAR Surgical directors over Alcon deal (Investing.com) -6.71%
06:17AM	Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors (Business Wire)
Oct-20-25 05:32PM	Yunqi Capital Issues Letter to STAAR Surgical's Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction (Business Wire) +5.41%
08:42AM	Broadwood Partners Highlights Growing Opposition to STAAR Surgicals Proposed Sale to Alcon (Business Wire)
07:30AM	STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025 (Business Wire)
Oct-17-25 08:00AM	Broadwood Partners Issues Letter to STAAR Surgical's Board Urging it to Allow Timely Shareholder Vote on Alcon Sale (Business Wire)
Oct-16-25 06:54PM	ISS recommendation may toll the bell for STAARAlcon deal, validates Broadwood (Investing.com) -5.97%
04:15PM	STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon (Business Wire)
Oct-15-25 01:36PM	Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon (Business Wire)
Oct-14-25 02:29PM	Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon (Business Wire)
Oct-12-25 08:02PM	Broadwood slams STAAR board over carelessness in Alcon sale defense (Investing.com)
Oct-10-25 01:11PM	Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale (Business Wire)
Oct-09-25 09:28AM	Glass Lewis recommends against STAARAlcon merger, bolstering Broadwoods campaign (Investing.com)
Oct-08-25 11:40AM	STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote "FOR" the Alcon Merger Agreement on WHITE Proxy Card (Business Wire)
11:16AM	Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote AGAINST Sale to Alcon (Business Wire)
08:00AM	Broadwood Partners Questions Integrity of STAAR Surgical's Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon (Business Wire)
Oct-07-25 11:25AM	Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon (PR Newswire)
Oct-06-25 04:01PM	Yunqi Capital, One of STAAR Surgical Company's Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon (Business Wire)
08:29AM	Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Judgment in Proposed Sale to Alcon (Business Wire)

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jiang Wei	Director	Jan 12 '26	Option Exercise	0.00	20,967	0	66,444	Jan 14 05:48 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 09 '26	Buy	22.05	27,485	606,138	15,453,629	Jan 13 09:30 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 06 '26	Buy	21.62	336,946	7,284,281	15,356,437	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 07 '26	Buy	22.00	66,467	1,462,301	15,422,904	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 08 '26	Buy	21.94	3,240	71,082	15,426,144	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 21 '25	Buy	27.86	797,486	22,218,837	15,019,491	Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 20 '25	Buy	27.14	393,382	10,675,325	14,222,005	Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 19 '25	Buy	26.42	309,132	8,166,155	13,828,623	Nov 21 09:55 PM
Jiang Wei	Director	Nov 12 '25	Option Exercise	0.00	20,967	0	45,477	Nov 14 06:00 PM
Jiang Wei	Director	Aug 12 '25	Option Exercise	0.00	20,967	0	24,510	Aug 13 06:39 PM
WEISNER AIMEE S	Former Director	Aug 05 '25	Proposed Sale	26.87	1,750	47,025		Aug 05 06:38 PM
WEISNER AIMEE S	Former Director	Aug 05 '25	Proposed Sale	26.87	13,491	362,523		Aug 05 06:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 08 '25	Buy	15.32	178,127	2,729,095	13,510,391	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 09 '25	Buy	15.08	8,200	123,676	13,518,591	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 10 '25	Buy	15.18	900	13,658	13,519,491	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 04 '25	Buy	15.91	497,631	7,917,191	13,194,210	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 03 '25	Buy	16.97	209,535	3,555,138	12,696,579	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 07 '25	Buy	15.61	138,054	2,155,174	13,332,264	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 02 '25	Buy	17.43	31,780	553,925	12,487,044	Apr 02 08:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 31 '25	Buy	17.46	22,189	387,360	12,455,264	Apr 02 08:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 26 '25	Buy	17.50	101,633	1,778,517	12,421,324	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 28 '25	Buy	17.47	8,131	142,014	12,433,075	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 27 '25	Buy	17.48	3,620	63,294	12,424,944	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 21 '25	Buy	17.74	102,400	1,816,545	12,285,395	Mar 25 07:02 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 25 '25	Buy	17.44	34,296	598,177	12,319,691	Mar 25 07:02 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 20 '25	Buy	17.96	108,720	1,952,992	12,182,995	Mar 20 07:51 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 18 '25	Buy	17.54	93,124	1,633,291	12,074,275	Mar 20 07:51 PM
Foust Warren	Chief Operating Officer	Mar 12 '25	Option Exercise	0.00	8,175	0	26,088	Mar 14 07:24 PM
Michna Magda	Chief Clinical, Regulatory,	Mar 12 '25	Option Exercise	0.00	6,177	0	18,554	Mar 14 07:21 PM
SISITSKY NATHANIEL	General Counsel	Mar 12 '25	Option Exercise	0.00	5,827	0	27,762	Mar 14 07:20 PM
Williams Patrick F.	Chief Financial Officer	Mar 12 '25	Option Exercise	0.00	8,153	0	56,242	Mar 14 07:19 PM
Williams Patrick F.	Chief Financial Officer	Mar 10 '25	Option Exercise	0.00	4,061	0	48,089	Mar 11 08:40 PM
Williams Patrick F.	Chief Financial Officer	Mar 07 '25	Option Exercise	0.00	5,689	0	44,028	Mar 11 08:40 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 04 '25	Buy	17.24	27,953	481,849	11,981,151	Mar 06 07:07 PM
FARRELL STEPHEN C	President & CEO	Mar 05 '25	Option Exercise	6.95	20,000	138,900	35,156	Mar 06 05:47 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 27 '25	Buy	17.05	259,316	4,420,106	11,548,753	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 03 '25	Buy	16.64	249,503	4,151,214	11,953,198	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 28 '25	Buy	17.45	154,942	2,704,235	11,703,695	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 12 '25	Buy	14.96	259,616	3,883,255	11,137,623	Feb 14 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 13 '25	Buy	15.84	115,282	1,825,514	11,252,905	Feb 14 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 14 '25	Buy	15.49	36,532	565,998	11,289,437	Feb 14 07:00 PM

GKOS

Glaukos Corporation

STAA

Staar Surgical Co

Upgrade your FINVIZ experience